Mark T. Esser

Also affiliated with AstraZeneca (Japan), AstraZeneca (United States)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail”.

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

Nature Microbiology(2021)10.1038/s41564-021-00972-2

N/A

9.6DataRank · unranked

330 citations

Seth J. Zost, Allison J. Greaney, Tyler N. Starr, Adam S. Dingens, Elaine C. Chen +27 more

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00215-6

N/A

4.5DataRank · unranked

128 citations

Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits +95 more

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

Critical Care(2022)10.1186/s13054-022-04204-9

N/A

2.1DataRank · unranked

94 citations

Bruno François, Marc Bourgeois, Apostolos Komnos, Ricard Ferrer, Galia Rahav +94 more

A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine

Science Translational Medicine(2022)10.1126/scitranslmed.ade0424

N/A

1.8DataRank · unranked

47 citations

Emily Phung, Michelle C. Crank, Kaitlyn M. Morabito, Tonya Villafana, Filip Dubovsky +7 more

DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2

Nature Communications(2022)10.1038/s41467-022-33309-6

N/A

0.520DataRank · unranked

31 citations

Jianqiu Du, Ali Ali, Katherine Schultheis, Drew Frase, Trevor R.F. Smith +27 more

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.10039

N/A

0.490DataRank · unranked

11 citations

Kara W Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan +47 more

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.09.443331

N/A

0.396DataRank · unranked

13 citations

Wei-Hung Chen, Rajeshwer S. Sankhala, Agnes Hajduczki, Paul V. Thomas, Misook Choe +53 more

SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity

SSRN Electronic Journal(2021)10.2139/ssrn.3854502

N/A

0.345DataRank · unranked

9 citations

Wei‐Hung Chen, Rajeshwer S. Sankhala, Agnes Hajduczki, Paul V. Thomas, Misook Choe +55 more

Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

iScience(2025)10.1016/j.isci.2025.111938

N/A

0.104DataRank · unranked

1 citations

Kara W Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan +14 more

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

Nature Communications(2022)10.1038/s41467-022-31615-7

N/A

0DataRank · unranked

154 citations

Samantha Mackin, John M. Errico, Zhenlu Chong, Emily A. Madden, Bradley Whitener +20 more

Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.27.428529

N/A

0DataRank · unranked

67 citations

Seth J. Zost, Allison J. Greaney, Tyler N. Starr, Adam S. Dingens, Elaine C. Chen +27 more

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.17.484787

N/A

0DataRank · unranked

37 citations

Samantha Mackin, John M. Errico, Zhenlu Chong, Emily A. Madden, Barbara Guarino +17 more

Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain

Structure(2023)10.1016/j.str.2023.11.015

N/A

0DataRank · unranked

22 citations

Vincent Dussupt, Wei‐Hung Chen, Hongjun Bai, Elizabeth J. Martinez, Jaime L. Jensen +40 more

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

Cell Reports(2021)10.1016/j.celrep.2021.110143

N/A

0DataRank · unranked

188 citations

Wei‐Hung Chen, Rajeshwer S. Sankhala, Agnes Hajduczki, Paul V. Thomas, Misook Choe +55 more

In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates

Emerging Microbes & Infections(2024)10.1080/22221751.2023.2294860

N/A

0DataRank · unranked

8 citations

Kyle Rosenke, Elizabeth M. Parzych, Friederike Feldmann, Suman Bharti, Amanda J. Griffin +24 more

A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.02.031

N/A

0DataRank · unranked

52 citations

Larissa V. Furtado, Ana I. Tergas, Nita K. Lee, Rebecca Brooks, Anne R. McCall +17 more